Conditions: Cataract Extraction
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 50
Healthy volunteers: no

Brief summary:
This study is being conducted to evaluate the intraocular penetration of Moxifloxacin 0.5% ophthalmic solution (Vigamox) and Besifloxacin 0.6% ophthalmic suspension (Besivance) after pre-operative topical administration in subjects undergoing cataract surgery.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Moxifloxacin 0.5% ophthalmic solution intervention 2: Besifloxacin 0.6% ophthalmic suspension
Intervention descriptions: intervention 1: Administer moxifloxacin study drug prior to cataract surgery. intervention 2: Administer besifloxacin study drug prior to cataract surgery.

Protocol document: